| CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts |
Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture |
Active, not recruiting |
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors |
Entecavir, Tenofovir Disoproxil Fumarate, Best Practice, Tenofovir Alafenamide |
Active, not recruiting |
| Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment |
Enhanced Usual Care, Pathways |
Recruiting |
| Informational Meetings for Planning and Coordinating Treatment |
Enhanced Usual Care Parent Education, Novel Communication Intervention |
Recruiting |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery |
Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration |
Active, not recruiting |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer |
Endocrine therapy interruption |
Active, not recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection |
Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid |
Active, not recruiting |
| Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States |
Electronic Health Record Review, Interview, Survey Administration |
Recruiting |
| Mobile Health for Adherence in Breast Cancer Patients |
Electronic Health Record Review, Health Promotion and Education, Health Telemonitoring, Interview, Patient Navigation, Survey Administration, Text Message-Based Navigation Intervention |
Recruiting |
| Chemoprevention of Gastric Carcinogenesis |
Eflornithine, Eflornithine placebo |
Active, not recruiting |